Chemical genetics of acetyl-CoA carboxylases

Molecules

Volumn 18, Issue 2, 2013, Pages 1704-1719

  Zu, Xuyu ^a   Zhong, Jing ^a   Luo, Dixian ^b   Tan, Jingjing ^a   Zhang, Qinghai ^a   Wu, Ying ^a   Liu, Jianghua ^a   Cao, Renxian ^a   Wen, Gebo ^a   Cao, Deliang ^c  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b THE FIRST PEOPLE S HOSPITAL OF CHENZHOU   (China)

^c SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ACC chemical genetics; ACC inhibitors; Acetyl CoA carboxylase; Cancer therapy; Fatty acid biosynthesis

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ENZYME INHIBITOR;

ANIMAL; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; PROTEIN PROCESSING; REVIEW;

ACETYL-COA CARBOXYLASE; ANIMALS; ENZYME INHIBITORS; HUMANS; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

MLCS; MLOWN;

EID: 84874609819     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18021704     Document Type: Review

References (113)

1. Harwood, H.J., Jr. Treating the metabolic syndrome: Acetyl-CoA carboxylase inhibition. Expert Opin. Ther. Targets 2005, 9, 267-281. (Pubitemid 40613868)
2. Harwood, H.J., Jr.; Petras, S.F.; Shelly, L.D.; Zaccaro, L.M.; Perry, D.A.; Makowski, M.R.; Hargrove, D.M.; Martin, K.A.; Tracey, W.R.; Chapman, J.G.; et al. Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl- CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals. J. Biol. Chem. 2003, 278, 37099-37111. (Pubitemid 37175224)
3. Reaven, G.M. Why Syndrome X? From Harold Himsworth to the insulin resistance syndrome. Cell Metab. 2005, 1, 9-14. (Pubitemid 43960585)
4. Kim, K.H. Regulation of mammalian acetyl-coenzyme A carboxylase. Annu. Rev. Nutr. 1997, 17, 77-99.
5. Tong, L. Acetyl-coenzyme A carboxylase: Crucial metabolic enzyme and attractive target for drug discovery. Cell. Mol. Life Sci. 2005, 62, 1784-1803. (Pubitemid 41188519)
6. Hannun, Y.A.; Obeid, L.M. The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J. Biol. Chem. 2002, 277, 25847-25850. (Pubitemid 34967060)
7. Tong, L.; Harwood, H.J., Jr. Acetyl-coenzyme A carboxylases: Versatile targets for drug discovery. J. Cell Biochem. 2006, 99, 1476-1488. (Pubitemid 44845709)
8. Carson, M. Ribbon models of macromoleculars. J. Mol. Graph. 1987, 5, 103-106.
9. Artymiuk, P.J.; Poirrette, A.R.; Rice, D.W.; Willett, P. Biotin carboxylase comes into the fold. Nat. Struct. Biol. 1996, 3, 128-132. (Pubitemid 26045001)
10. Galperin, M.Y.; Koonin, E.V. A diverse superfamily of enzymes with ATP-dependent carboxylate-amine/thiol ligase activity. Protein Sci. 1997, 6, 2639-2643. (Pubitemid 28006703)
11. Thoden, J.B.; Blanchard, C.Z.; Holden, H.M.; Waldrop, G.L. Movement of the biotin carboxylase B-domain as a result of ATP binding. J. Biol. Chem. 2000, 275, 16183-16190. (Pubitemid 30366930)
12. Waldrop, G.L.; Rayment, I.; Holden, H.M. Three-dimensional structure of the biotin carboxylase subunit of acetyl-CoA carboxylase. Biochemistry 1994, 33, 10249-10256. (Pubitemid 24281789)
13. Zhang, H.; Yang, Z.; Shen, Y.; Tong, L. Crystal structure of the carboxyltransferase domain of acetyl-coenzyme A carboxylase. Science 2003, 299, 2064-2067. (Pubitemid 36383732)
14. Fall, R.R.; Vagelos, P.R. Acetyl coenzyme A carboxylase. Molecular forms and subunit composition of biotin carboxyl carrier protein. J. Biol. Chem. 1972, 247, 8005-8015.
15. Nenortas, E.; Beckett, D. Purification and characterization of intact and truncated forms of the Escherichia coli biotin carboxyl carrier subunit of acetyl-CoA carboxylase. J. Biol. Chem. 1996, 271, 7559-7567. (Pubitemid 26107032)
16. Polyak, S.W.; Abell, A.D.; Wilce, M.C.; Zhang, L.; Booker, G.W. Structure, function and selective inhibition of bacterial acetyl-coa carboxylase. Appl. Microbiol. Biotechnol. 2012, 93, 983-992.
17. Goldman, P.; Alberts, A.W.; Vagelos, P.R. Requirement for a malonyl CoA-CO2 exchange reaction in long chain but not short chain fatty acid synthesis in Clostridium Kluvveri. Biochem. Biophys. Res. Commun. 1961, 5, 280-285.
18. Seubert, W.; Lamberts, I.; Kramer, R.; Ohly, B. On the mechanism of malonyl-CoA-independent fatty acid synthesis. I. The mechanism of elongation of long-chain fatty acids by acetyl-CoA. Biochim. Biophys. Acta 1968, 164, 498-517.
19. Ventura, F.V.; Costa, C.G.; Ijist, L.; Dorland, L.; Duran, M.; Jakobs, C.; Tavares de Almeida, I.; Wanders, R.J.A. Broad specificity of carnitine palmitoyltransferase II towards long-chain acyl-CoA beta-oxidation intermediates and its practical approach to the synthesis of various long-chain acylcarnitines. J. Inherit. Metab. Dis. 1997, 20, 423-426. (Pubitemid 27354632)
20. Diacovich, L.; Peiru, S.; Kurth, D.; Rodriguez, E.; Podesta, F.; Khosla, C.; Gramajo, H. Kinetic and structural analysis of a new group of Acyl-CoA carboxylases found in Streptomyces coelicolor A3(2). J. Biol. Chem. 2002, 277, 31228-31236. (Pubitemid 34970830)
21. Lee, J.J.; Moon, Y.A.; Ha, J.H.; Yoon, D.J.; Ahn, Y.H.; Kim, K.S. Cloning of human acetyl-CoA carboxylase beta promoter and its regulation by muscle regulatory factors. J. Biol. Chem. 2001, 276, 2576-2585.
22. Atkinson, L.L.; Fischer, M.A.; Lopaschuk, G.D. Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl- CoA axis. J. Biol. Chem. 2002, 277, 29424-29430. (Pubitemid 41079226)
23. Foufelle, F.; Ferre, P. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: A role for the transcription factor sterol regulatory element binding protein-1c. Biochem. J. 2002, 366, 377-391. (Pubitemid 35001682)
24. Oh, S.Y.; Park, S.K.; Kim, J.W.; Ahn, Y.H.; Park, S.W.; Kim, K.S. Acetyl-CoA carboxylase beta gene is regulated by sterol regulatory element-binding protein-1 in liver. J. Biol. Chem. 2003, 278, 28410-28417.
25. Eberle, D.; Hegarty, B.; Bossard, P.; Ferre, P.; Foufelle, F. SREBP transcription factors: Master regulators of lipid homeostasis. Biochimie 2004, 86, 839-848. (Pubitemid 39602764)
26. Zhao, L.F.; Iwasaki, Y.; Zhe, W.; Nishiyama, M.; Taguchi, T.; Tsugita, M.; Kambayashi, M.; Hashimoto, K.; Terada, Y. Hormonal regulation of acetyl-CoA carboxylase isoenzyme gene transcription. Endocr. J. 2010, 57, 317-324.
27. Murayama, Y.; Mochizuki, K.; Shimada, M.; Fujimoto, S.; Nukui, K.; Shibata, K. Dietary supplementation with alpha-amylase inhibitor wheat albumin to high-fat diet-induced insulinresistant rats is associated with increased expression of genes related to fatty acid synthesis in adipose tissue. J. Agric. Food Chem. 2009, 57, 9332-9338.
28. Yoon, S.; Lee, M.Y.; Park, S.W.; Moon, J.S.; Koh, Y.K.; Ahn, Y.H.; Park, B.W.; Kim, K.S. Up-regulation of acetyl-CoA carboxylase alpha and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells. J. Biol. Chem. 2007, 282, 26122-26131. (Pubitemid 47443806)
29. Park, S.H.; Gammon, S.R.; Knippers, J.D.; Paulsen, S.R; Rubink, D.S.; Winder, W.W. Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle. J. Appl. Physiol. 2002, 92, 2475-2482. (Pubitemid 34666373)
30. Rubink, D.S.; Winder, W.W. Effect of phosphorylation by AMP-activated protein kinase on palmitoyl-CoA inhibition of skeletal muscle acetyl-CoA carboxylase. J. Appl. Physiol. 2005, 98, 1221-1227. (Pubitemid 40396493)
31. Hardie, D.G. Regulation of fatty acid and cholesterol metabolism by the AMP-activated protein kinase. Biochim. Biophys. Acta 1992, 1123, 231-238.
32. Munday, M.R. Regulation of mammalian acetyl-CoA carboxylase. Biochem. Soc. Trans. 2002, 30, 1059-1064. (Pubitemid 36002406)
33. Barber, M.C.; Price, N.T.; Travers, M.T. Structure and regulation of acetyl-CoA carboxylase genes of metazoa. Biochim. Biophys. Acta 2005, 1733, 1-28. (Pubitemid 40321169)
34. Magnard, C.; Bachelier, R.; Vincent, A.; Jaquinod, M.; Kieffer, S.; Lenoir, G.M.; Venezia, N.D. BRCA1 interacts with acetyl-CoA carboxylase through its tandem of BRCT domains. Oncogene 2002, 21, 6729-6739. (Pubitemid 35221915)
35. Shen, Y.; Tong, L. Structural evidence for direct interactions between the BRCT domains of human BRCA1 and a phospho-peptide from human ACC1. Biochemistry 2008, 47, 5767-5773. (Pubitemid 351747055)
36. Lenhard, J.M.; Gottschalk, W.K. Preclinical developments in type 2 diabetes. Adv. Drug. Deliv. Rev. 2002, 54, 1199-1212. (Pubitemid 35230001)
37. Harwood, H.J., Jr. Acetyl-CoA carboxylase inhibition for the treatment of metabolic syndrome. Curr. Opin. Investig. Drugs. 2004, 5, 283-289.
38. Bar-Tana, J.; Ben-Shoshan, S.; Blum, J.; Migron, Y.; Hertz, R.; Pill, J.; Rose-Khan, G.; Witte, E.C. Synthesis and hypolipidemic and antidiabetogenic activities of beta,beta,beta',beta'- tetrasubstituted, long-chain dioic acids. J. Med. Chem. 1989, 32, 2072-2084. (Pubitemid 19224168)
39. Berge, R.K.; Skorve, J.; Tronstad, K.J.; Berge, K.; Gudbrandsen, O.A.; Grav, H. Metabolic effects of thia fatty acids. Curr. Opin. Lipidol. 2002, 13, 295-304. (Pubitemid 34592287)
40. Russell, J.C.; Amy, R.M.; Graham, S.E.; Dolphin, P.J.; Wood, G.O.; Bar-Tana, J. Inhibition of atherosclerosis and myocardial lesions in the JCR:LA-cp rat by beta, beta'- tetramethylhexadecanedioic acid (MEDICA 16). Arterioscler Thromb. Vasc. Biol. 1995, 15, 918-923.
41. Tzur, R.; Rose-Kahn, G.; Adler, J.H.; Bar-Tana, J. Hypolipidemic, antiobesity, and hypoglycemic-hypoinsulinemic effects of beta,beta'-methyl- substituted hexadecanedioic acid in sand rats. Diabetes 1988, 37, 1618-1624. (Pubitemid 19004943)
42. Skrede, S.; Sorensen, H.N.; Larsen, L.N.; Steineger, H.H.; Hovik, K.; Spydevold, O.S.; Horn, R.; Bremer, J. Thia fatty acids, metabolism and metabolic effects. Biochim. Biophys. Acta 1997, 1344, 115-131. (Pubitemid 27046437)
43. Bremer, J. The biochemistry of hypo- and hyperlipidemic fatty acid derivatives: Metabolism and metabolic effects. Prog. Lipid. Res. 2001, 40, 231-268. (Pubitemid 32544958)
44. Abu-Elheiga, L.; Matzuk, M.M.; Abo-Hashema, K.A.; Wakil, S.J. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 2001, 291, 2613-2616. (Pubitemid 32249687)
45. Moreau, K.; Dizin, E.; Ray, H.; Luquain, C.; Lefai, E.; Foufelle, F.; Billaud, M.G.; Lenoir, M.; Venezia, N.D. BRCA1 affects lipid synthesis through its interaction with acetyl-CoA carboxylase. J. Biol. Chem. 2006, 281, 3172-3181. (Pubitemid 43845927)
46. Sreekrishna, K.; Gunsberg, S; Wakil, S.J.; Joshi, V.C. Interaction of the fluorescent analogue stearoyl-(1,N6)-etheno coenzyme A with chicken liver acetyl coenzyme A carboxylase. J. Biol. Chem. 1980, 255, 3348-3351.
47. Wakil, S.J.; Stoops, J.K.; Joshi, V.C. Fatty acid synthesis and its regulation. Annu. Rev. Biochem. 1983, 52, 537-579. (Pubitemid 13030689)
48. Ogiwara, H.; Tanabe, T.; Nikawa, J.; Numa, S. Inhibition of rat-liver acetyl-coenzyme-A carboxylase by palmitoyl-coenzyme A. Formation of equimolar enzyme-inhibitor complex. Eur. J. Biochem. 1978, 89, 33-41. (Pubitemid 8402075)
49. Kamiryo, T.; Nishikawa, Y.; Mishina, M.; Terao, M.; Numa, S. Involvement of long-chain acyl coenzyme A for lipid synthesis in repression of acetyl-coenzyme A carboxylase in Candida lipolytica. Proc. Natl. Acad. Sci. USA 1979, 76, 4390-4394. (Pubitemid 9256567)
50. Nikawa, J.; Tanabe, T.; Ogiwara, H.; Shiba, T.; Numa, S. Inhibitory effects of long-chain acyl coenzyme A analogues on rat liver acetyl coenzyme A carboxylase. FEBS Lett. 1979, 102, 223-226.
51. Cramer, C.T.; Goetz, B.; Hopson, K.L.; Fici, G.J.; Ackermann, R.M.; Brown, S.C. Bisgaier, C.L.; Rajeswaran, W.G.; Oniciu, D.C.; Pape, M.E. Effects of a novel dual lipid synthesis inhibitor and its potential utility in treating dyslipidemia and metabolic syndrome. J. Lipid. Res. 2004, 45, 1289-1301. (Pubitemid 38802632)
52. Cao, D.; Fan, S.T.; Chung, S.S. Identification and characterization of a novel human aldose reductase-like gene. J. Biol. Chem. 1998, 273, 11429-11435. (Pubitemid 28272034)
53. Zu, X; Yan, R.; Robbins, S.; Krishack, P.A.; Liao, D.F.; Cao, D. Reduced 293T cell susceptibility to acrolein due to aldose reductase-like-1 protein expression. Toxicol. Sci. 2007, 97, 562-568. (Pubitemid 47073870)
54. Yan, R.; Zu, X.; Ma, J.; Liu, Z; Adeyanju, M.; Cao, D. Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention. Int. J. Cancer 2007, 121, 2301-2306. (Pubitemid 47585613)
55. Ma, J.; Luo, D.X.; Huang, C.; Shen, Y.; Bu, Y.; Markwell, S.; Gao, J.; Liu, J.; Zu, X.; Cao, Z.; et al. AKR1B10 overexpression in breast cancer: association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker. Int. J. Cancer 2012, 131, E862-E871.
56. Wang, C.; Yan, R.; Luo, D.; Watabe, K.; Liao, D.F.; Cao, D. Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls. J. Biol. Chem. 2009, 284, 26742-26748.
57. Ma, J.; Yan, R.; Zu, X.; Cheng, J.M.; Rao, K.; Liao, DF.; Cao, D. Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells. J. Biol. Chem. 2008, 283, 3418-3423.
58. Gerth, K.; Bedorf, N.; Irschik, H.; Hofle, G.; Reichenbach, H. The soraphens: A family of novel antifungal compounds from Sorangium cellulosum (Myxobacteria). I. Soraphen A1 alpha: fermentation, isolation, biological properties. J. Antibiot. (Tokyo) 1994, 47, 23-31. (Pubitemid 24045521)
59. Gerth, K.; Pradella, S.; Perlova, O.; Beyer, S.; Muller, R. Myxobacteria: Proficient producers of novel natural products with various biological activities - Past and future biotechnological aspects with the focus on the genus Sorangium. J. Biotechnol. 2003, 106, 233-253. (Pubitemid 37494861)
60. Trost, B.M.; Sieber, J.D.; Qian, W.; Dhawan, R.; Ball, Z.T. Asymmetric total synthesis of soraphen A: A flexible alkyne strategy. Angew. Chem. Int. Ed. Engl. 2009, 48, 5478-5481.
61. Jump, D.B.; Torres-Gonzalez, M.; Olson, L.K. Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation. Biochem. Pharmacol. 2011, 81, 649-660.
62. Schreurs, M.; van Dijk, T.H.; Gerding, A; Havinga, R.; Reijngoud, D.J.; Kuipers. F. Soraphen, an inhibitor of the acetyl-CoA carboxylase system, improves peripheral insulin sensitivity in mice fed a high-fat diet. Diabetes Obes. Metable. 2009, 11, 987-991.
63. Shen, Y.; Volrath, S.L.; Weatherly, S.C.; Elich, T.D.; Tong, L. A mechanism for the potent inhibition of eukaryotic acetyl-coenzyme A carboxylase by soraphen A, a macrocyclic polyketide natural product. Mol. Cell. 2004, 16, 881-891. (Pubitemid 40018399)
64. Wan, H.; Sjolinder, M; Schairer, H.U; Leclerque, A. A new dominant selection marker for transformation of Pichia pastoris to soraphen A resistance. J. Microbiol. Methods 2004, 57, 33-39. (Pubitemid 38299349)
65. Weatherly, S.C; Volrath, S.L.; Elich, T.D. Expression and characterization of recombinant fungal acetyl-CoA carboxylase and isolation of a soraphen-binding domain. Biochem. J. 2004, 380, 105-110. (Pubitemid 38725734)
66. Kemp, B.E.; Stapleton, D.; Campbell, D.J.; Chen, Z.P.; Murthy, S.; Walter, M.; Gupta, A.; Adams, J.J.; Katsis, F.; van Denderen, B.; et al. AMP-activated protein kinase, super metabolic regulator. Biochem. Soc. Trans. 2003, 31, 162-168. (Pubitemid 36241420)
67. Viollet, B.; Andreelli, F.; Jorgensen, S.B.; Perrin, C.; Flamez, D.; Mu, J.; Wojtaszewski, J.F.; Schuit, F.C.; Birnbaum, M.; Richter, E.; et al. Physiological role of AMP-activated protein kinase (AMPK): Insights from knockout mouse models. Biochem. Soc. Trans. 2003, 31, 216-219. (Pubitemid 36241431)
68. McCune, S.A.; Harris, R.A. Mechanism responsible for 5-(tetradecyloxy)-2- furoic acid inhibition of hepatic lipogenesis. J. Biol. Chem. 1979, 254, 10095-10101. (Pubitemid 10162030)
69. Parker, R.A.; Kariya, T.; Grisar, J.M. Petrow V. 5-(Tetradecyloxy)-2- furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids. J. Med. Chem. 1977, 20, 781-791. (Pubitemid 8096806)
70. Arbeeny, C.M.; Meyers, D.S.; Bergquist, K.E.; Gregg, R.E. Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster. J. Lipid. Res. 1992, 33, 843-851.
71. Fukuda, N.; Ontko, J.A. Interactions between fatty acid synthesis, oxidation, and esterification in the production of triglyceride-rich lipoproteins by the liver. J. Lipid. Res. 1984, 25, 831-842. (Pubitemid 14032393)
72. Kempen, H.J.; Imbach, A.P.; Giller, T.; Neumann, W.J.; Hennes, U.; Nakada, N. Secretion of apolipoproteins A-I and B by HepG2 cells: regulation by substrates and metabolic inhibitors. J. Lipid. Res. 1995, 36, 1796-1806.
73. Triscari, J.; Sullivan, A.C. Anti-obesity activity of a novel lipid synthesis inhibitor. Int. J. Obes. 1984, 8, 227-239. (Pubitemid 15019744)
74. Halvorson, D.L.; McCune, S.A. Inhibition of fatty acid synthesis in isolated adipocytes by 5-(tetradecyloxy)-2-furoic acid. Lipids 1984, 19, 851-856. (Pubitemid 15188497)
75. Sola, M.M.; Oliver, F.J.; Salto, R.; Gutierrez, M.; Vargas, A. Citrate inhibition of rat-kidney cortex phosphofructokinase. Mol. Cell Biochem. 1994, 135, 123-128. (Pubitemid 24307922)
76. Wang, C.; Xu, C.; Sun, M.; Luo, D.; Liao, D.F.; Cao, D. Acetyl-CoA carboxylase-alpha inhibitor TOFA induces human cancer cell apoptosis. Biochem. Biophys. Res. Commun. 2009, 385, 302-306.
77. Hess, D.; Chisholm, J.W.; Igal, R.A. Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells. PLoS One 2010, 5, e11394.
78. Beckers, A.; Organe, S.; Timmermans, L.; Scheys, K.; Peeters, A.; Brusselmans, K.; Verhoeven, G.; Swinnen, J.V. Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells. Cancer Res. 2007, 67, 8180-8187. (Pubitemid 47395154)
79. Sugimoto, Y.; Naniwa, Y.; Nakamura, T.; Kato, H.; Yamamoto, M.; Tanabe, H.; Inoue, K.; Imaizumi, A. A novel acetyl-CoA carboxylase inhibitor reduces de novo fatty acid synthesis in HepG2 cells and rat primary hepatocytes. Arch. Biochem. Biophys. 2007, 468, 44-48. (Pubitemid 350087850)
80. Frenkel, B.; Bishara-Shieban, J.; Bar-Tana, J. The effect of beta,beta'- tetramethylhexadecanedioic acid (MEDICA 16) on plasma very-low-density lipoprotein metabolism in rats: role of apolipoprotein C-III. Biochem. J. 1994, 298, 409-414. (Pubitemid 24072485)
81. Bar-Tana, J.; Rose-Kahn, G; Srebnik, M. Inhibition of lipid synthesis by beta beta'-tetramethylsubstituted, C14-C22, alpha, omega-dicarboxylic acids in the rat in vivo. J. Biol. Chem. 1985, 260, 8404-8410. (Pubitemid 15249849)
82. Russell, J.C.; Shillabeer, G.; Bar-Tana, J.; Lau, D.C.; Richardson, M.; Wenzel, L.M.; Graham, S.E.; Dolphin, P.J. Development of insulin resistance in the JCR:LA-cp rat: Role of triacylglycerols and effects of MEDICA 16. Diabetes 1998, 47, 770-778. (Pubitemid 28201807)
83. Mayorek, N.; Kalderon, B.; Itach, E.; Bar-Tana, J. Sensitization to insulin induced by beta,beta'- methyl-substituted hexadecanedioic acid (MEDICA 16) in obese Zucker rats in vivo. Diabetes 1997, 46, 1958-1964. (Pubitemid 27512080)
84. Hermesh, O.; Kalderon, B; Bar-Tana, J. Mitochondria uncoupling by a long chain fatty acyl analogue. J. Biol. Chem. 1998, 273, 3937-3942.
85. Levert, K.L.; Waldrop, G.L.; Stephens, J.M. A biotin analog inhibits acetyl-CoA carboxylase activity and adipogenesis. J. Biol. Chem. 2002, 277, 16347-16350. (Pubitemid 34967642)
86. Ohno, T.; Yano, S.; Yamada, H.; Shirasaka, T.; Yamamoto, A.; Kobayashi, K.; Ogawa, K. Synthesis of the optical isomers of 4-[1-(4-tert-butylphenyl)-2- oxo- pyrrolidine-4- yl]methyloxybenzoic acid (S-2) and their biological evaluation as antilipidemic agent. Chem. Pharm. Bull. (Tokyo). 1999, 47, 1549-1554. (Pubitemid 30002087)
87. Ohmori, K.; Yamada, H.; Yasuda, A.; Yamamoto, A.; Matsuura, N.; Kiniwa, M. Anti-hyperlipidemic action of a newly synthesized benzoic acid derivative, S-2E. Eur. J. Pharmacol. 2003, 471, 69-76. (Pubitemid 36694861)
88. Ohmori, K.; Yamada, H.; Yasuda, A.; Yamamoto, A.; Matsuura, N.; Kiniwa, M. Effects of a novel antihyperlipidemic agent, S-2E, on the blood lipid abnormalities in homozygous WHHL rabbits. Metabolism 2004, 53, 680-685. (Pubitemid 38596545)
89. Gargazanli, G.L.; Frost, J.; George, P. 5-Naphthalen-1-YL-1,3Dioxane derivatives preparation and therapeutic application . WO9855474 A1, 1998.
90. Zoller, G.; Schmoll, D.; Mueller, M.; Haschke, G.; Focken, I. Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof. WO2010003624 A2, 2010.
91. Swinnen, J.V.; Heemers, H.; van de Sande, T.; de Schrijver, E.; Brusselmans, K.; Heyns, W.; Verhoeven, G. Androgens, lipogenesis and prostate cancer. J. Steroid. Biochem. Mol. Biol. 2004, 92, 273-279.
92. Rouquette-Jazdanian, A.K.; Pelassy, C.; Breittmayer, J.P; Cousin, J.L; Aussel, C. Metabolic labelling of membrane microdomains/rafts in Jurkat cells indicates the presence of glycerophospholipids implicated in signal transduction by the CD3 T-cell receptor. Biochem. J. 2002, 363, 645-655. (Pubitemid 34526385)
93. Simons, K.; Toomre, D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell. Biol. 2000, 1, 31-39.
94. Manes, S.; Mira, E.; Gomez-Mouton, C.; Lacalle, R.A.; Keller, P.; Labrador, J.P.; Martinez-A, C. Membrane raft microdomains mediate front-rear polarity in migrating cells. EMBO J. 1999, 18, 6211-6220. (Pubitemid 29533225)
95. Medes, G.; Thomas, A.; Weinhouse, S. Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res. 1953, 13, 27-29.
96. Ookhtens, M.; Kannan, R.; Lyon, I.; Baker, N. Liver and adipose tissue contributions to newly formed fatty acids in an ascites tumor. Am. J. Physiol. 1984, 247, R146-R153. (Pubitemid 14090895)
97. Sabine, J.R.; Abraham, S.; Chaikoff, I.L. Control of lipid metabolism in hepatomas: Insensitivity of rate of fatty acid and cholesterol synthesis by mouse hepatoma BW7756 to fasting and to feedback control. Cancer Res. 1967, 27, 793-799.
98. Swinnen, J.V.; Brusselmans, K.; Verhoeven, G. Increased lipogenesis in cancer cells: New players, novel targets. Curr. Opin. Clin. Nutr. Metab. Care 2006, 9, 358-365. (Pubitemid 44101970)
99. Milgraum, L.Z.; Witters, L.A.; Pasternack, G.R.; Kuhajda, F.P. Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clin. Cancer Res. 1997, 3, 2115-2120. (Pubitemid 27505140)
100. Yahagi, N.; Shimano, H.; Hasegawa, K.; Ohashi, K.; Matsuzaka, T.; Najima, Y.; Sekiya, M.; Tomita, S.; Okazaki, H.; Tamura, Y.; et al. Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma. Eur. J. Cancer 2005, 41, 1316-1322. (Pubitemid 40813009)
101. Moncur, J.T.; Park, J.P.; Memoli, V.A.; Mohandas, T.K.; Kinlaw, W.B. The "Spot 14" gene resides on the telomeric end of the 11q13 amplicon and is expressed in lipogenic breast cancers: Implications for control of tumor metabolism. Proc. Natl. Acad. Sci. USA 1998, 95, 6989-6994.
102. Swinnen, J.V.; Vanderhoydonc, F.; Elgamal, A.A.; Eelen, M.; Vercaeren, I.; Joniau, S.; Van Poppel, H.; Baert, L.; Goossens, K.; Heyns, W.; et al. Selective activation of the fatty acid synthesis pathway in human prostate cancer. Int. J. Cancer 2000, 88, 176-179.
103. Claus, E.B.; Stowe, M.; Carter, D.; Holford, T. The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: Data from the Connecticut Tumor Registry. Breast 2003, 12, 451-456. (Pubitemid 38008659)
104. Pizer, E.S.; Pflug, B.R.; Bova, G.S.; Han, W.F.; Udan, M.S.; Nelson, J.B. Increased fatty acid synthase as a therapeutic target in androgen-independent prostate cancer progression. Prostate 2001, 47, 102-110. (Pubitemid 32336579)
105. Savage, D.B.; Choi, C.S.; Samuel, V.T.; Liu, Z.X.; Zhang, D.; Wang, A.; Zhang, X.M.; Cline, G.W.; Yu, X.X.; Geisler, J.G.; et al. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. J. Clin. Invest. 2006, 116, 817-824. (Pubitemid 43326891)
106. Chajes, V.; Cambot, M.; Moreau, K.; Lenoir, G.M.; Joulin, V. Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival. Cancer Res. 2006, 66, 5287-5294. (Pubitemid 43844953)
107. Brusselmans, K.; De Schrijver, E.; Verhoeven, G.; Swinnen, J.V. RNA interference-mediated silencing of the acetyl-CoA-carboxylase-alpha gene induces growth inhibition and apoptosis of prostate cancer cells. Cancer Res. 2005, 65, 6719-6725. (Pubitemid 41060709)
108. Sinilnikova, O.M.; Ginolhac, S.M.; Magnard, C.; Leone, M.; Anczukow, O.; Hughes, D.; Moreau, K.; Thompson, D.; Coutanson, C.; Hall, J.; et al. Acetyl-CoA carboxylase alpha gene and breast cancer susceptibility. Carcinogenesis 2004, 25, 2417-2424. (Pubitemid 39625182)
109. Samudio, I.; Harmancey, R.; Fiegl, M.; Kantarjian, H.; Konopleva, M.; Korchin, B.; Kaluarachchi, K.; Bornmann, W.; Duvvuri, S.; Taegtmeyer, H.; et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J. Clin. Invest. 2010, 120, 142-156.
110. Andela, V.B.; Altuwaijri, S.; Wood, J.; Rosier, R.N. Inhibition of beta-oxidative respiration is a therapeutic window associated with the cancer chemo-preventive activity of PPARgamma agonists. FEBS Lett. 2005, 579, 1765-1769. (Pubitemid 40341555)
111. Zhou, W.; Tu, Y.; Simpson, P.J.; Kuhajda, F.P. Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to human breast cancer cells. Oncogene 2009, 28, 2979-2987.
112. Ruderman, N.; Prentki, M. AMP kinase and malonyl-CoA: Targets for therapy of the metabolic syndrome. Nat. Rev. Drug Discov. 2004, 3, 340-351. (Pubitemid 38499761)
113. Koistinen, H.A.; Galuska, D.; Chibalin, A.V.; Yang, J.; Zierath JR, Holman, G.D.; Wallberg-Henriksson, H. 5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. Diabetes 2003, 52, 1066-1072. (Pubitemid 36523338)